Select Medical Holdings (SEM) Cost of Revenue (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cost of Revenue data on file, last reported at $1.2 billion in Q1 2026.

• Quarterly Cost of Revenue rose 6.26% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 6.33% YoY) and the FY2025 annual result came in at $4.8 billion, up 5.93% from the prior year.
• Cost of Revenue steadied at $1.2 billion in Q1 2026 per SEM's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $1.4 billion in Q1 2022 and bottomed at $16.3 million in Q4 2022.
• The 5-year median for Cost of Revenue is $1.2 billion (2025), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Cost of Revenue plunged 98.84%; it then soared 6485.7% in 2023.
• Tracing SEM's Cost of Revenue over 5 years: stood at $16.3 million in 2022, then soared by 6485.7% to $1.1 billion in 2023, then increased by 9.41% to $1.2 billion in 2024, then gained by 6.44% to $1.3 billion in 2025, then decreased by 0.38% to $1.2 billion in 2026.
• Per Business Quant, the three latest SEM Cost of Revenue figures stand at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025).

Peer Comparison